Wave Life Sciences WVE Return on equity

Return on equity at other companies

Eli LillyLLY

102.4%+15.7pp

Sarepta Therapeutics, Inc.SRPT

-9.3%+2,662pp

Ionis PharmaceuticalsIONS

-105.5%+336pp

Madrigal Pharmaceuticals, Inc.MDGL

-53.3%+47.0pp

ALN

Alnylam PharmaceuticalsALNY

91.4%—

Beam TherapeuticsBEAM

-47.1%—

FAQ

What is Wave Life Sciences's return on equity?

Wave Life Sciences (WVE) reported return on equity of -68.3% in Q2 2026.

What is the long-term trend for Wave Life Sciences's return on equity?

Over 2 years (2020 to 2025), Wave Life Sciences's return on equity has grown at a -47.6% compound annual growth rate (CAGR), from -204.6% to -56.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.